| Similar Articles |
|---|
 |
The Motley Fool
June 21, 2004
Rich Duprey |
aaiPharma Feels the Pain The maker of painkiller Darvocet restates its earnings for the prior two years.   |
The Motley Fool
August 13, 2004
Rich Duprey |
Cima's Breakup Mess The pharmaceutical company seeks to recoup its fees plus damages from a former suitor. |
InternetNews
December 30, 2003
Roy Mark |
Symbol's CEO Exits as Accounting Probe Unwinds The 24-year veteran of wireless bar code-scanning device company exits in order to help put a 'channel stuffing' probe behind it. |
The Motley Fool
April 16, 2004
Rich Smith |
DoubleClick's Pinched Penny Rounding earnings per share can lay traps for unwary investors. Online advertiser DoubleClick becomes a good lesson in why it is best to think of those little ticker symbols scrolling by as pieces of companies rather than little ticker symbols. |
The Motley Fool
March 3, 2004
Bill Mann |
A Tale of Two Companies If you're going to refer to other people's research to inform your investing opinions (and you should -- there are great resources out there), you still have to take responsibility for your ultimate opinion and decision. |
The Motley Fool
April 7, 2005
Rich Duprey |
Gambling on aaiPharma's Bankruptcy Some investors take a flier as this specialty pharmaceutical careens toward bankruptcy. |
The Motley Fool
February 5, 2004
Philip Durell |
Underwater Options May Sink FTI Can the consulting firm overcome the desertion of some of its senior consultants? Its falling share price creates a risk of employee defections as their stock options tank. |
The Motley Fool
November 2, 2004
Brian Gorman |
aaiPharma Steadies Itself Investors applauded aaiPharma's restructuring, but the company has plenty of challenges ahead. |
The Motley Fool
July 15, 2004
Brian Gorman |
Research Company's Stock Surges PPD's (formerly Pharmaceutical Product Development) second-quarter report isn't perfect, but long-term indicators look solid. The stock has risen as much as 14%. |
IndustryWeek
March 1, 2002
John S. McClenahen |
Goodbye To GAAP? Probably not. But Enron's collapse makes changes in financial regulation likely... |
The Motley Fool
July 28, 2005
Chuck Saletta |
Let Cash Be Your Guide Use the cash flow statement to weed out financial shenanigans and uncover hidden stock values. |
The Motley Fool
September 13, 2004
Rich Duprey |
A Bird's-Eye Test for Profits Comparing operating cash flows with net income lets investors weed out disasters early. Take a look at Best Buy and Circuit City. |
The Motley Fool
July 1, 2004
Brian Gorman |
Charles River's Big Buy Charles River Laboratories is buying Inveresk Research Group in what appears to be a bid to control more of the burgeoning market for preclinical drug development services. |
The Motley Fool
August 24, 2006 |
Stuffing the Channel Investors, beware of companies shipping inventory ahead of schedule. Since companies often record sales as soon as they ship products, channel stuffing can make it appear that business is booming. |
The Motley Fool
December 24, 2003 |
Stuffing the Channel When a company stuffs the channel, it ships inventory ahead of schedule. In a sense, sales are made at the expense of sales in future quarters. Here are tips for determining if companies you are investing in are stuffing the channel. |
